These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 16145220

  • 1. Selection of an empiric antibiotic regimen for hospital-acquired pneumonia using a unit and culture-type specific antibiogram.
    Green DL.
    J Intensive Care Med; 2005; 20(5):296-301. PubMed ID: 16145220
    [Abstract] [Full Text] [Related]

  • 2. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
    Wei HJ, Liu LL, Xiaoli LY, Wang YP, Huang D, Pian HY, Zhu YC.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
    [Abstract] [Full Text] [Related]

  • 3. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    Bennett KM, Scarborough JE, Sharpe M, Dodds-Ashley E, Kaye KS, Hayward TZ, Vaslef SN.
    J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
    [Abstract] [Full Text] [Related]

  • 4. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S, Fujitani S, Potoski BA, Capitano B, Linden PK, Shutt K, Paterson DL.
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [Abstract] [Full Text] [Related]

  • 5. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D, Hilbert G, Vargas F, Valentino R, Bui N, Pereyre S, Bebear C, Bebear CM, Gbikpi-Benissan G.
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [Abstract] [Full Text] [Related]

  • 6. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS, Frei CR.
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [Abstract] [Full Text] [Related]

  • 7. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.
    Hughes MG, Evans HL, Chong TW, Smith RL, Raymond DP, Pelletier SJ, Pruett TL, Sawyer RG.
    Crit Care Med; 2004 Jan; 32(1):53-60. PubMed ID: 14707559
    [Abstract] [Full Text] [Related]

  • 8. The choice of empirical antibiotic therapy for nosocomial pneumonia.
    Ramirez JA.
    J Chemother; 1994 Apr; 6 Suppl 2():47-50. PubMed ID: 7799054
    [Abstract] [Full Text] [Related]

  • 9. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 10. Making the most of surveillance studies: summary of the OPTAMA Program.
    Kuti JL, Nicolau DP.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):281-7. PubMed ID: 16360552
    [Abstract] [Full Text] [Related]

  • 11. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
    Sligl W, Taylor G, Brindley PG.
    Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
    [Abstract] [Full Text] [Related]

  • 12. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A, Karmakar PS, Pal J, Chakraborty N, Debnath NB, Mukherjee JD.
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [Abstract] [Full Text] [Related]

  • 13. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S.
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [Abstract] [Full Text] [Related]

  • 14. [A rare cause of pneumonia: Shewanella putrefaciens].
    Durdu B, Durdu Y, Güleç N, Islim F, Biçer M.
    Mikrobiyol Bul; 2012 Jan; 46(1):117-21. PubMed ID: 22399180
    [Abstract] [Full Text] [Related]

  • 15. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
    Patzer JA, Dzierzanowska D, Turner PJ.
    J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
    [Abstract] [Full Text] [Related]

  • 16. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R.
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [Abstract] [Full Text] [Related]

  • 17. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
    Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME.
    Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
    [Abstract] [Full Text] [Related]

  • 18. Advances in the management of pneumonia in the intensive care unit: review of current thinking.
    Rello J, Diaz E, Rodríguez A.
    Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():30-8. PubMed ID: 16138817
    [Abstract] [Full Text] [Related]

  • 19. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA, Mauldin PD, Steed LL.
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [Abstract] [Full Text] [Related]

  • 20. Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay.
    Kuster SP, Ruef C, Zbinden R, Gottschalk J, Ledergerber B, Neuber L, Weber R.
    J Antimicrob Chemother; 2008 Dec; 62(6):1451-61. PubMed ID: 18776189
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.